Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 1 completed trials have results

Key Signals

2 recruiting

Enrollment Performance

Analytics

N/A
1(100.0%)
1Total
N/A(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT07485244Recruiting

EEG Abnormalities in Adult ICU Patients With High Risk of Delirium

Role: lead

NCT07449416Not ApplicableNot Yet Recruiting

Ceribell Delirium Monitor Outcomes Pilot Study

Role: lead

NCT04962815Recruiting

Ceribell Delirium Data Collection Study

Role: lead

NCT03534258Completed

Does Use of Rapid Response EEG Impact Clinical Decision Making

Role: lead

All 4 trials loaded